OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,424 | +17.1% | 24,850 | 0.0% | 0.00% | – |
| Q2 2023 | $81,508 | -35.3% | 24,850 | -20.7% | 0.00% | – |
| Q1 2021 | $126,000 | -17.1% | 31,332 | +18.5% | 0.00% | – |
| Q3 2020 | $152,000 | -25.1% | 26,446 | 0.0% | 0.00% | – |
| Q2 2020 | $203,000 | +2437.5% | 26,446 | +2515.8% | 0.00% | – |
| Q2 2018 | $8,000 | +14.3% | 1,011 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | -61.1% | 1,011 | -44.6% | 0.00% | – |
| Q4 2017 | $18,000 | +125.0% | 1,824 | +95.5% | 0.00% | – |
| Q3 2017 | $8,000 | – | 933 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |